Search
Menu
Home
HTB
2005
May
HTB
May 2005
Contents
Editorial
Volume 6 Number 5 May 2005
Conference reports
3rd European HIV Drug Resistance Workshop, 30 March-1 April 2005, Athens
Tenofovir, nucleosides, and non-nucleosides
Protease inhibitors
CCR5 antagonists
Paediatric reports from 12th Conference on Retrovirus and Opportunistic Infections (CROI)
Once-daily lopinavir/ritonavir for children may offer advantages
Lopinavir/ritonavir for young infants
Paediatric dose finding atazanavir and atazanavir/ritonavir
Switching d4T to tenofovir and protease inhibitor to efavirenz
Treatment access
Millions in Global Fund grants go unused: Indian government bureaucracies kill off people living with AIDS
Paediatric care
US guidelines on paediatric care updated (March 2005)
Guidelines
Draft BHIVA treatment guidelines online for comment
UK guidelines for liver transplant in HIV-positive patients
Coinfections and complications
Lymphogranuloma venereum – an overview: update on UK cases of LGV
Hepatitis coinfection
Sexual HCV reinfection of HIV-positive gay man while receiving PEG-interferon plus ribavirin
First European recommendations for the treatment of patients co-infected with HIV and HBV/HCV
Other news
Newly acquired HIV infections are key to transmission
Calls to i-Base phoneline now free from Orange mobile networks
Request for overseas volunteers
On the web
40th European Association for the Study of the Liver (EASL)
Community impact of New York case of HIV infection with multidrug-resistant dual-tropic HIV-1 and rapid progression to AIDS
Integration of buprenorphine into primary HIV care
HIV inSite Knowledge Base
PDFs
Volume 6 Number 5 May 2005 PDF
HTB RSS
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage